An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats

Chandra Ramakrishnan; Simone Maier; Robert A. Walker; Hubert Rehrauer; Deborah E. Joekel; Rahel R. Winiger; Walter U. Basso; Michael E. Grigg; Adrian B. Hehl; Peter Deplazes; Nicholas C. Smith

doi:10.1038/s41598-018-37671-8

An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats

Chandra Ramakrishnan, Simone Maier, Robert A. Walker, Hubert Rehrauer, Deborah E. Joekel, Rahel R. Winiger, Walter U. Basso, Michael E. Grigg, Adrian B. Hehl, Peter Deplazes, Nicholas C. Smith

Western Sydney University

Research output: Contribution to journal › Article › peer-review

111 Citations (Scopus)

Abstract

Almost any warm-blooded creature can be an intermediate host for Toxoplasma gondii. However, sexual reproduction of T. gondii occurs only in felids, wherein fertilisation of haploid macrogametes by haploid microgametes, results in diploid zygotes, around which a protective wall develops, forming unsporulated oocysts. Unsporulated oocysts are shed in the faeces of cats and meiosis gives rise to haploid sporozoites within the oocysts. These, now infectious, sporulated oocysts contaminate the environment as a source of infection for people and their livestock. RNA-Seq analysis of cat enteric stages of T. gondii uncovered genes expressed uniquely in microgametes and macrogametes. A CRISPR/Cas9 strategy was used to create a T. gondii strain that exhibits defective fertilisation, decreased fecundity and generates oocysts that fail to produce sporozoites. Inoculation of cats with this engineered parasite strain totally prevented oocyst excretion following infection with wild-type T. gondii, demonstrating that this mutant is an attenuated, live, transmission-blocking vaccine.

Original language	English
Article number	1474
Number of pages	15
Journal	Scientific Reports
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41598-018-37671-8
Publication status	Published - 2019

Open Access - Access Right Statement

Â© The Author(s) 2019. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Keywords

Toxoplasma gondii
cats
toxoplasmosis

Access to Document

10.1038/s41598-018-37671-8

Cite this

@article{c53c88a68ff04c809a0b8aa0314cecd2,

title = "An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats",

abstract = "Almost any warm-blooded creature can be an intermediate host for Toxoplasma gondii. However, sexual reproduction of T. gondii occurs only in felids, wherein fertilisation of haploid macrogametes by haploid microgametes, results in diploid zygotes, around which a protective wall develops, forming unsporulated oocysts. Unsporulated oocysts are shed in the faeces of cats and meiosis gives rise to haploid sporozoites within the oocysts. These, now infectious, sporulated oocysts contaminate the environment as a source of infection for people and their livestock. RNA-Seq analysis of cat enteric stages of T. gondii uncovered genes expressed uniquely in microgametes and macrogametes. A CRISPR/Cas9 strategy was used to create a T. gondii strain that exhibits defective fertilisation, decreased fecundity and generates oocysts that fail to produce sporozoites. Inoculation of cats with this engineered parasite strain totally prevented oocyst excretion following infection with wild-type T. gondii, demonstrating that this mutant is an attenuated, live, transmission-blocking vaccine.",

keywords = "Toxoplasma gondii, cats, toxoplasmosis",

author = "Chandra Ramakrishnan and Simone Maier and Walker, {Robert A.} and Hubert Rehrauer and Joekel, {Deborah E.} and Winiger, {Rahel R.} and Basso, {Walter U.} and Grigg, {Michael E.} and Hehl, {Adrian B.} and Peter Deplazes and Smith, {Nicholas C.}",

year = "2019",

doi = "10.1038/s41598-018-37671-8",

language = "English",

volume = "9",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats

AU - Ramakrishnan, Chandra

AU - Maier, Simone

AU - Walker, Robert A.

AU - Rehrauer, Hubert

AU - Joekel, Deborah E.

AU - Winiger, Rahel R.

AU - Basso, Walter U.

AU - Grigg, Michael E.

AU - Hehl, Adrian B.

AU - Deplazes, Peter

AU - Smith, Nicholas C.

PY - 2019

Y1 - 2019

N2 - Almost any warm-blooded creature can be an intermediate host for Toxoplasma gondii. However, sexual reproduction of T. gondii occurs only in felids, wherein fertilisation of haploid macrogametes by haploid microgametes, results in diploid zygotes, around which a protective wall develops, forming unsporulated oocysts. Unsporulated oocysts are shed in the faeces of cats and meiosis gives rise to haploid sporozoites within the oocysts. These, now infectious, sporulated oocysts contaminate the environment as a source of infection for people and their livestock. RNA-Seq analysis of cat enteric stages of T. gondii uncovered genes expressed uniquely in microgametes and macrogametes. A CRISPR/Cas9 strategy was used to create a T. gondii strain that exhibits defective fertilisation, decreased fecundity and generates oocysts that fail to produce sporozoites. Inoculation of cats with this engineered parasite strain totally prevented oocyst excretion following infection with wild-type T. gondii, demonstrating that this mutant is an attenuated, live, transmission-blocking vaccine.

AB - Almost any warm-blooded creature can be an intermediate host for Toxoplasma gondii. However, sexual reproduction of T. gondii occurs only in felids, wherein fertilisation of haploid macrogametes by haploid microgametes, results in diploid zygotes, around which a protective wall develops, forming unsporulated oocysts. Unsporulated oocysts are shed in the faeces of cats and meiosis gives rise to haploid sporozoites within the oocysts. These, now infectious, sporulated oocysts contaminate the environment as a source of infection for people and their livestock. RNA-Seq analysis of cat enteric stages of T. gondii uncovered genes expressed uniquely in microgametes and macrogametes. A CRISPR/Cas9 strategy was used to create a T. gondii strain that exhibits defective fertilisation, decreased fecundity and generates oocysts that fail to produce sporozoites. Inoculation of cats with this engineered parasite strain totally prevented oocyst excretion following infection with wild-type T. gondii, demonstrating that this mutant is an attenuated, live, transmission-blocking vaccine.

KW - Toxoplasma gondii

KW - cats

KW - toxoplasmosis

UR - http://handle.westernsydney.edu.au:8081/1959.7/uws:51131

U2 - 10.1038/s41598-018-37671-8

DO - 10.1038/s41598-018-37671-8

M3 - Article

SN - 2045-2322

VL - 9

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 1474

ER -

An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats

Abstract

Open Access - Access Right Statement

Keywords

Access to Document

Other files and links

Fingerprint

Cite this